These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2417353)

  • 1. On the significance of antithrombin-III, alpha 2-macroglobulin, alpha 2-antiplasmin, histidine-rich glycoprotein, and protein C in patients with acute myocardial infarction and deep vein thrombosis.
    Gram J; Jespersen J
    Thromb Haemost; 1985 Aug; 54(2):503-5. PubMed ID: 2417353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
    Gram J
    Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sequential study of plasma histidine-rich glycoprotein and plasminogen in patients with acute myocardial infarction and deep vein thrombosis.
    Jespersen J; Gram J; Bach E
    Thromb Haemost; 1984 Feb; 51(1):99-102. PubMed ID: 6719393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluctuation of thrombin-antithrombin III complex in patients with acute myocardial infarction: influence of low-dose heparin administration.
    Psuja P; Lewandowski K; Turowiecka Z; Zozulińska M; Tokarz A; Zawilska K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(2):229-36. PubMed ID: 1697824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood coagulation and fibrinolysis inhibitory factors].
    Imaoka S; Sasaki Y; Terasawa T
    Rinsho Byori; 1985 Jun; Spec No 63():55-61. PubMed ID: 2413229
    [No Abstract]   [Full Text] [Related]  

  • 6. Levels of antithrombin III, alpha 2-macroglobulin, and alpha 1-antitrypsin in acute ischemic heart disease.
    Losito R; Gattiker H; Bilodeau G; Verville N; Longpré B
    J Lab Clin Med; 1981 Feb; 97(2):241-50. PubMed ID: 6161197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of coagulation and fibrinolysis in 131 cases of recurrent deep vein thrombosis].
    Conard J; Veuillet-Duval A; Horellou MH; Samama M
    Nouv Rev Fr Hematol (1978); 1982; 24(3):205-9. PubMed ID: 7133990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of decreasing antithrombin III in deep-vein thrombosis.
    Andreasen TL
    Thromb Haemost; 1980 Dec; 44(3):135-7. PubMed ID: 7466739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis.
    Heijboer H; Brandjes DP; Büller HR; Sturk A; ten Cate JW
    N Engl J Med; 1990 Nov; 323(22):1512-6. PubMed ID: 2146503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood changes in atherosclerosis and long after myocardial infarction and venous thrombosis.
    O'Brien JR; Etherington MD; Jamieson S; Lawford P; Lincoln SV; Alkjaersig NJ
    Thromb Diath Haemorrh; 1975 Nov; 34(2):483-97. PubMed ID: 53892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein C dynamics in peripheral arterial occlusive diseases and myocardial infarction: association of homozygous protein C deficiency with heterozygous dysplasminogenemia found among patients with deep vein thrombosis].
    Manabe S
    Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):220-30. PubMed ID: 3754930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual levels of plasma alpha 2-antiplasmin and alpha 2-macroglobulin during the normal menstrual cycle and in women on oral contraceptives low in oestrogen.
    Jespersen J; Sidelmann J
    Thromb Haemost; 1983 Aug; 50(2):581-5. PubMed ID: 6195752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in inflammatory markers in acute myocardial infarction: a longitudinal study.
    Napoleão P; Santos MC; Selas M; Viegas-Crespo AM; Pinheiro T; Ferreira RC
    Rev Port Cardiol; 2007 Dec; 26(12):1357-63. PubMed ID: 18338665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
    Bloemenkamp KW; Rosendaal FR; Helmerhorst FM; Koster T; Bertina RM; Vandenbroucke JP
    Thromb Haemost; 1998 Sep; 80(3):382-7. PubMed ID: 9759614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Plasma proteinase inhibitors and their clinical significance].
    Prandota J; Kotecki L
    Pediatr Pol; 1995 Aug; 70(8):667-72. PubMed ID: 8668369
    [No Abstract]   [Full Text] [Related]  

  • 16. Fibrinogen, factor VIII related antigen, antithrombin III and alpha 2-antiplasmin in peripheral arterial disease.
    Christe M; Delley A; Marbet GA; Biland L; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):240-2. PubMed ID: 6442467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of protein C and its distribution between its inhibitors, protein C inhibitor, alpha 1-antitrypsin and alpha 2-macroglobulin, in patients with disseminated intravascular coagulation.
    Scully MF; Toh CH; Hoogendoorn H; Manuel RP; Nesheim ME; Solymoss S; Giles AR
    Thromb Haemost; 1993 May; 69(5):448-53. PubMed ID: 7686692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombin III, plasminogen, plasmin, and alpha-2-antiplasmin in donor blood and plasma components.
    McRoyan DK; McRoyan CJ; Sauter KL; Liu PI; Daniel SJ
    Ann Clin Lab Sci; 1985; 15(2):165-70. PubMed ID: 3158265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiologic evaluation of deep venous thrombosis: hemostasis tests to perform].
    Sie P
    Ann Biol Clin (Paris); 1985; 43(6):817-9. PubMed ID: 3841708
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.